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The densities (ρ) and speeds of sound (u) for glycine in aqueous solutions of (0.01, 0.02, 0.03, and 0.04) mol·kg-1 
sulphathiazole drug have been measured at T = (288.15, 293.15, 298.15, 303.15 and 308.15) K, using vibrating tube digital 
densimeter and sound analyser Anton–Paar Model DSA - 5000. The apparent molar properties like apparent molar volume 
(𝑉𝜑 ), apparent molar adiabatic compressibility (𝐾𝜑 ,𝑠) and the apparent molar volume (𝑉𝜑
0) and adiabatic compressibility at
infinite dilution (𝐾𝜑 ,𝑠
0) of glycine have been determined in water as well as in ternary mixtures containing sulphathiazole
drug at different concentrations and at different temperatures from experimental data of densities and speeds of sound under 
atmospheric pressure. These data were also used to calculate the transfer parameters. Transfer parameters have been 
explained from the point of view of concentration dependence of solute-solute and solute-solvent interactions. The limiting 
apparent molar expansibility (𝐸𝜑
∘ ) values for glycine in aqueous solutions of drug have been calculated. The calculated 
values of thermal expansion coefficient (𝛼2) have small and positive values. These results are explained on the basis of
drug-amino acid - water interactions and hydrophobic –hydrophilic interactions. 
Keywords: Glycine, Sulphathiazole, Apparent molar volume, Apparent molar adiabatic compressibility, Solute-solute and 
solute-solvent interactions 
Various biological processes involve volume 
changes and hydration of molecules, and their 
complete understanding needs a proper idea of the 
state and the behaviour of the molecules in the 
medium
1,2
. Further, proteins are essential components 
of living organisms. Proteins stimulate various 
biological reactions. However, the direct study of 
interactions of protein in solution is too difficult 
because of their complex structure. Generally, the 
functioning of protein is monitored by studying their 
component molecules, amino acids
3,4
. The behaviour 
of biomolecules in mixtures is affected by many 
factors such as chemical structure, pH, surface charge 
distribution, and type of electrolyte present and its 
concentration. The effect of the presence of 
electrolytes in solutions of biochemicals is of interest 
in a number of separation processes, such as the 
reverse micellar extraction of amino acids and 
proteins which may not occur without the presence of 
an electrolyte
5,6
. Furthermore, electrolytes are known 
to influence the stability of biologically important 
molecules such as proteins
7,8
. In addition, amino acids 
are the building blocks of other biomolecules such as 
peptides and proteins. Thus, it is important to study 
their behaviour in aqueous systems containing 
electrolytes. The interactions of water with the 
functional groups of proteins play important factor in 
determining the conformational stability of 
proteins
9,10
. Non-bonding interactions such as 
hydrogen bonding, electrostatic and hydrophobic 
interactions are also important in the stabilization of 
native conformations of biological macromolecules. 
The study of the solvent effect on the properties of 
model compounds such as amino acids is quite 




Although viscosity and partial molar volume 
properties of amino acids in aqueous electrolyte 
solutions have been extensively studied by many 
research groups
12
, Physico-chemical properties of 
drugs are of interest to know during action at the 
molecular level. The action of a drug must be 
regarded as the vital outcome of physicochemical 
interactions between the drug and functionally 
important molecules in the living organism. Most 
drugs are organic molecules with both solvophylic 




and solvophobic groups due to which these molecules 
show specific as well as electrostatic interactions. 
Hence, knowledge of the physicochemical properties 
of the drugs plays an important role in understanding 
their physicochemical actions which are highly 
dependent on the solution behaviour. Volumetric  
data of drug can provide clues to the interaction 
occurring in cellular fluids. Amino acid exists as 
zwitterionic species in aqueous solutions, thus their 
thermodynamic properties in a variety of media can 




The partial molar volume and the related 
volumetric parameters of drug compounds in dilute 
aqueous solutions at different temperatures have been 
investigated by several authors
2,14-17
. The drug–water 
molecular interaction and their temperature 
dependence are useful in the understanding of drug 
action. It is generally accepted that proteins stabilize 
because of hydrophobic effect
18
, although there was a 
dispute reported by Makhatadze and Privalov
19
 who 
predicts that binding model describes well but then 
Franks
20
 strongly argued in the article ―Protein 
stability‖ regarding involvement of hydrophobicity 
rather than binding which is responsible for 
solubilizing and denaturing effects. Although no 
definite principle has been laid down in predicting the 
effect of solvent on the structure and reactivity of 
solutes, but much progress has been achieved
21,22
. 
Sulphathiazole is an organosulfur compound that 
has been used as a short-acting sulfa drug. It once was 
a common oral and topical antimicrobial until less 
toxic alternatives were discovered. It is still 
occasionally used, sometimes in combination with 
sulfabenzamide and sulfacetamide, and in aquariums. 
Recently, the study of small peptides, the building 
block of proteins having significant biological and 
industrial importance, has attracted wide interest as 
their peptides contain more complex structure and 
more components of proteins than amino acids. 
Further, these peptides are widely used in many 
applications mainly, in the pharmaceutical, food and 
chemical industries. There have been some source 
investigators in aqueous saccharide solutions
23-26
 but 
very few in aqueous drug solutions
27-31
 probably due 
to complex nature of their interactions. Therefore, the 
systematic study of peptides can provide valuable 
information about their behavior in solutions and 
insight into the hydration of biological systems in 
presence of drug solutions. Thus, from practical and 
academic point of view, it is necessary to investigate 
the solvation behaviour with small peptides in drug 
solutions at different temperatures. Furthermore, such 
kind of studies can enlighten the interaction behaviour 
of drug in biomolecular mixed systems. For this 
purpose, in the present paper we report the density 
and speed of sound measurements of glycine in 
aqueous drug solutions at T= (288.15 to 308.15) K 
and at atmospheric pressure from which the values for 
infinite dilution of apparent molar volumes are 
calculated with the help of least-square method
32
. The 
limiting apparent molar volumes and limiting 
apparent molar adiabatic compressibilities have been 
calculated in order to discuss the types of interactions 
occurring in the present systems. 
 
Materials and Methods 
Glycine was procured from Hi Media, India 
minimum assay 99.0% and used after drying over 
silica gel in a vacuum desiccator at room temperature. 
Sulphathiazole from Sigma Chemicals Co. were dried 
for 24 h in a vacuum desiccator before use. The 
structure of this drug is given in Fig. 1. 
All solutions were prepared using deionized doubly 





 that have been freshly degassed 
by vacuum pump). Solutions of glycine in the 
concentration range of 0.05 to 0.30 mol·kg
-1
 were 
made by mass on the molality concentration scale 
with an accuracy of  1 × 10
−5
. The weighing were  
done on an Afcoset electronic balance (India, Model 
ER-182A) with a precision of  0.01 mg.  
The uncertainties in the solution molalities were  




. Densities and speeds 
of sound, of glycine in aqueous sulphathiazole 
solutions at different temperatures were measured 
simultaneously and automatically, using an Anton 
Paar (model DSA 5000) vibrating-tube densimeter. 
Both the speed of sound and the density are  
extremely sensitive to temperature and hence, it was 
controlled to ± 1 × 10
−2
 K by a built-in solid state 
thermostat. The apparatus was also tested with the 
density of a known molality of aqueous NaCl using 
the data given by Pitzer et al.
33
.The reproducibility of 
 
 
Fig. 1 — Structure of sulphathiazole drug 




the instrument corresponded to a precision in density 









. The uncertainty of the density  
and speed of sound estimates was found to be less 








. Before  
each series of measurements, the instrument was  
pre-calibrated with doubly distilled, deionized, 
degassed water, and dry air for the temperature  
range investigated. The absorption spectra of  
samples were recorded on Double beam UV-visible 
spectrophotometer. 
 
Results and Discussion 
 
Density, speed of sound and partial molar properties 
The values of the density, and speed of sound,  
for glycine in aqueous solutions of sulphathiazole  
at T = (288.15, 293.15, 298.15, 303.15 and 308.15) K 
are reported in Table 1. The apparent molar  

























0.01 mB sulphathiazole + glycine 
0.00000 1.000325 1469.92 0.999405 1486.13 0.998225 1499.61 0.996810 1511.66 0.995183 1521.47 
0.05051 1.001954 1471.82 1.000999 1487.96 0.999801 1501.32 0.998370 1513.34 0.996725 1523.12 
0.10054 1.003564 1473.93 1.002577 1489.99 1.001362 1503.39 0.999915 1515.36 0.998254 1525.08 
0.15023 1.005160 1476.26 1.004144 1492.36 1.002911 1505.74 1.001450 1517.75 0.999774 1527.37 
0.19879 1.006716 1478.71 1.005674 1494.98 1.004425 1508.44 1.002950 1520.39 1.001260 1529.96 
0.25038 1.008366 1481.64 1.007298 1498.17 1.006032 1511.56 1.004543 1523.76 1.002841 1533.09 
0.29747 1.009870 1484.55 1.008779 1501.36 1.007497 1514.70 1.005997 1526.89 1.004284 1536.31 
0.02 mB sulphathiazole + glycine 
0.00000 1.001475 1470.95 1.000544 1486.78 0.999354 1500.61 0.997930 1512.41 0.996291 1523.07 
0.05029 1.003078 1472.96 1.002112 1488.77 1.000898 1502.51 0.999454 1514.27 0.997784 1524.89 
0.09996 1.004661 1475.15 1.003661 1491.02 1.002425 1504.65 1.000963 1516.39 0.999263 1526.96 
0.14933 1.006233 1477.59 1.005202 1493.66 1.003945 1507.09 1.002468 1518.79 1.000739 1529.36 
0.19938 1.007826 1480.23 1.006765 1496.75 1.005487 1509.83 1.003997 1521.54 1.002243 1532.09 
0.25102 1.009468 1483.28 1.008378 1500.43 1.007081 1512.87 1.005581 1524.72 1.003798 1535.23 
0.29572 1.010890 1486.09 1.009775 1503.85 1.008461 1515.93 1.006954 1528.02 1.005149 1538.29 
0.03 mB sulphathiazole + glycine 
0.00000 1.003074 1471.32 1.002033 1487.38 1.000707 1501.37 0.999146 1513.51 0.997492 1523.96 
0.04983 1.004575 1473.59 1.003500 1489.56 1.002156 1503.52 1.000571 1515.66 0.998905 1526.08 
0.09992 1.006080 1476.07 1.004980 1491.94 1.003621 1505.87 1.002018 1517.99 1.000343 1528.39 
0.14983 1.007574 1478.74 1.006458 1494.53 1.005089 1508.42 1.003476 1520.57 1.001793 1530.85 
0.20001 1.009073 1481.53 1.007949 1497.36 1.006571 1511.28 1.004956 1523.39 1.003269 1533.54 
0.24928 1.010540 1484.49 1.009415 1500.29 1.008034 1514.31 1.006427 1526.36 1.004736 1536.36 
0.29986 1.012042 1487.77 1.010929 1503.53 1.009545 1517.59 1.007944 1529.79 1.006264 1539.67 
0.04 mB sulphathiazole + glycine 
0.00000 1.004068 1472.75 1.003103 1488.63 1.001801 1502.49 1.000261 1514.55 0.998595 1524.89 
0.05055 1.005538 1475.27 1.004537 1491.07 1.003199 1504.92 1.001646 1516.96 0.999965 1527.19 
0.10055 1.006994 1477.99 1.005971 1493.68 1.004611 1507.45 1.003049 1519.61 1.001358 1529.66 
0.14987 1.008435 1480.88 1.007399 1496.46 1.006029 1510.21 1.004461 1522.36 1.00277 1532.23 
0.20139 1.009943 1484.09 1.008909 1499.61 1.007544 1513.2 1.005973 1525.39 1.004279 1534.98 
0.24766 1.011301 1487.23 1.010283 1502.58 1.008931 1515.97 1.007355 1528.31 1.005668 1537.61 
0.29883 1.012811 1490.76 1.011818 1505.99 1.010491 1519.09 1.008923 1531.55 1.007236 1540.76 




volumes (𝑉𝜑 ) and the apparent molar adiabatic 
compressibilities (𝐾𝜑 ,𝑠) of glycine in aqueous 
sulphathiazole solution were calculated from the 
experimentally measured densities and speeds of 
sound using the following equations and are given in 
Table 2. 
𝑉𝜑 =  
𝑀
𝜌
 −  1000 𝜌 − 𝜌𝑜 𝑚𝐴𝜌𝜌𝑜  … (1) 
𝐾𝜑 ,𝑠 =  (M𝛽𝑠/)  {1000 (𝛽𝑠,𝑜𝛽𝑠𝜌𝑜  )/𝑚𝐴𝜌𝑜}  … (2) 
where, M is the molar mass of glycine, and ρ, ρo, S 
and S,0 are the densities and coefficient of adiabatic 
compressibilities of solution and the solvent 
(drug+water), respectively and mA is the molality of 
solute, that is, glycine in aqueous sulphathiazole. The 
coefficients of adiabatic compressibilities were 




) … (3) 
For the dilute solutions used in the present study, 
the variation of 𝑉𝜑  and 𝐾𝜑 ,𝑠 with molality can be 
represented by the following equation, 
𝑌𝜑 = 𝑌𝜑
𝑜 + 𝑆𝑄𝑚𝐴 … (4) 
where 𝑌𝜑
0 (denotes 𝑉𝜑
0 or 𝐾𝜑 ,𝑠
0 ) is the limiting value of 
partial molar property (equal to the infinite dilution 
Table 2 — Apparent molar volume (𝑉𝜑) and apparent molar adiabatic compressibility (𝐾𝜑 ,𝑠) of glycine in aqueous solutions of 





6/ (m3 mol-1) 𝐾𝜑 ,𝑠·10
6/ (m3 mol-1GPa-1) 
288.15 293.15 298.15 303.15 308.15 288.15 293.15 298.15 303.15 308.15 
0.01 mB sulphathiazole + glycine 
0.05051 42.74 43.45 43.82 44.16 44.54 -19.0 -16.8 -14.4 -13.2 -12.0 
0.10054 42.71 43.39 43.75 44.09 44.45 -20.6 -18.2 -16.8 -15.4 -14.0 
0.15023 42.67 43.32 43.69 44.02 44.37 -22.2 -20.3 -18.8 -17.7 -16.1 
0.19879 42.64 43.27 43.63 43.95 44.29 -23.6 -22.3 -21.1 -19.8 -18.2 
0.25038 42.61 43.21 43.57 43.88 44.21 -25.4 -25.4 -23.2 -22.4 -20.4 
0.29747 42.57 43.16 43.52 43.82 44.14 -27.0 -27.0 -25.1 -24.3 -22.5 
0.02 mB sulphathiazole + glycine 
0.05029 43.11 43.81 44.31 44.72 45.37 -20.3 -18.5 -16.4 -14.7 -13.4 
0.09996 43.04 43.74 44.22 44.62 45.26 -21.7 -20.4 -18.1 -16.6 -15.1 
0.14933 42.98 43.66 44.13 44.51 45.14 -23.4 -22.8 -20.0 -18.5 -17.1 
0.19938 42.92 43.59 44.05 44.40 45.00 -24.9 -25.4 -21.9 -20.5 -19.1 
0.25102 42.87 43.51 43.95 44.28 44.88 -26.7 -28.2 -23.6 -22.6 -21.1 
0.29572 42.81 43.44 43.88 44.18 44.77 -28.1 -30.4 -25.5 -25.0 -22.9 
0.03 mB sulphathiazole + glycine 
0.04983 44.83 45.53 45.91 46.42 46.69 -22.4 -19.7 -18.3 -17.1 -15.9 
0.09992 44.81 45.41 45.76 46.21 46.45 -23.8 -21.1 -19.6 -18.4 -17.3 
0.14983 44.79 45.30 45.61 45.98 46.21 -25.1 -22.5 -21.0 -20.0 -18.5 
0.20001 44.76 45.19 45.47 45.77 45.96 -26.2 -24.1 -22.7 -21.6 -19.8 
0.24928 44.74 45.09 45.33 45.54 45.72 -27.4 -25.4 -24.3 -23.1 -21.2 
0.29986 44.71 44.97 45.18 45.34 45.46 -28.8 -26.8 -25.8 -24.9 -23.0 
0.04 mB sulphathiazole + glycine 
0.04983 45.85 46.58 47.31 47.60 47.93 -24.2 -21.6 -20.0 -18.8 -16.6 
0.09992 45.77 46.36 46.95 47.20 47.49 -25.8 -23.1 -21.2 -20.7 -18.2 
0.14983 45.66 46.15 46.63 46.84 47.04 -27.3 -24.6 -22.8 -22.2 -19.5 
0.20001 45.56 45.92 46.25 46.43 46.60 -28.8 -26.3 -24.2 -23.6 -20.6 
0.24928 45.47 45.70 45.92 46.09 46.21 -30.3 -27.7 -25.3 -25.0 -21.8 
0.29986 45.35 45.46 45.56 45.68 45.78 -31.6 -29.0 -26.4 -26.2 -23.2 




partial molar property) and SQ (denotes Sv or SK) is 
the experimental or limiting slope. 
The 𝑉𝜑  and 𝐾𝜑 ,𝑠 data have been used to see the 
effect of temperature and drug concentration on 
solute-solvent interactions occurring in the ternary 
mixture of the present study. Hence, 𝑉𝜑
0 and 𝐾𝜑 ,𝑠
0  at 
infinite dilution obtained by the least square fitting  
of 𝑉𝜑  and 𝐾𝜑 ,𝑠data using Eqn 4 are summarized in 
Table 3. At infinite dilution, the solute-solute 
interactions (that is, from the experimental slopes  
Sv or SK) are negligible; therefore, the standard  
partial molar volume with temperature dependence 




Table 3 reveals that glycine studied here has large 
positive 𝑉𝜑
0 values and negative 𝐾𝜑 ,𝑠
0  values in  
aqueous sulphathiazole solutions at all investigated 
temperatures, which indicates the presence of strong 
amino acid-drug-water
24
 interactions. The 𝑉𝜑
0 values 
increase with increase in temperature and also with 
increase in the concentration of sulphathiazole. It 
indicates that solute-solvent interactions are 
increasing both with an increase in the concentration 
of sulphathiazole and temperature. Moreover, the 𝐾𝜑 ,𝑠
0  
values are negative for glycine in aqueous 
sulphathiazole solutions. The negative 𝐾𝜑 ,𝑠
0  values 
indicate that water molecules around the solute are 
less compressible than water present in the  
bulk. Usually, partial molar volumes 𝑉𝜑
0 and 
compressibilities 𝐾𝜑 ,𝑠
0  at infinite dilution are 
correlated in such way that the compressibility 
increases as the volume increases
25
. Further, it can be 
seen from Table 3, the values of 𝐾𝜑 ,𝑠
0  become  
more negative with increase in concentration of 
sulphathiazole and less negative with increase in 
temperature indicating the release of more water 
molecules from the secondary solvation layer of 
sulphathiazole into the bulk. This feature is similar to 
that observed for glycine in aqueous solutions of 
saccharides
24,32
. The experimental 𝑆𝑉  values in  
Table 3 for glycine in sulphathiazole are found to  
be negative, suggesting that solute-solute interactions  
are weaker than solute-solvent interactions in the 
system under study. 
Table 3 — Partial molar properties, 𝑉𝜑
0 and 𝐾𝜑 ,𝑠
∘  and their corresponding slopes, Sv and SK of glycine in aqueous solutions of 
sulphathiazole drug at different temperatures 
T(K) 
 288.15 293.15 298.15 303.15 308.15 
0.01 mB sulphathiazole + glycine 
𝑉𝜑
0·106 (m3 mol-1) 42.77(±0.003) 43.50(±0.005) 43.87(±0.004) 44.35(±0.02) 44.61(±0.004) 
Sv·10
6 (m3 kg1/2mol-3/2) -0.68(±0.02) -1.17((±0.02) -1.21(±0.02) -1.38(±0.012) -1.61(±0.02) 
𝐾𝜑 ,𝑠
∘ ·106 (m3 mol-1GPa-1) -17.28(±0.10) -14.14(±0.41) -12.34(±0.12) -10.88(±0.09) -9.76(±0.06) 
SK ·10
6 ( kg m3 mol-2GPa-1) -32.31(±0.55) -43.06(±2.15) -43.28(±0.63) -45.36(±0.51) -42.58(±0.33) 
0.02 mB sulphathiazole + glycine 
𝑉𝜑
0·106 (m3 mol-1) 43.16(±0.003) 44.00(±0.004) 44.53(±0.004) 45.15(±0.02) 45.50(±0.006) 
Sv·10
6 (m3 kg1/2mol-3/2) -1.19(±0.02) -1.97((±0.02) -1.75(±0.02) -3.22(±0.08) -2.47(±0.03) 
𝐾𝜑 ,𝑠
∘ ·106 (m3 mol-1GPa-1) -18.59(±0.08) -15.65(±0.25) -14.48(±0.09) -12.47(±0.21) -11.31(±0.08) 
SK ·10
6 ( kg m3 mol-2GPa-1) -32.07(±0.42) -34.32(±0.56) -36.91(±0.51) -41.53(±1.11) -39.00(±0.43) 
0.03 mB sulphathiazole + glycine 
𝑉𝜑
0·106 (m3 mol-1) 44.85(±0.004) 45.63(±0.004) 46.06(±0.005) 46.63(±0.008) 46.94(±0.013) 
Sv·10
6 (m3 kg1/2mol-3/2) -1.46(±0.02) -2.21((±0.02) -2.92(±0.02) -4.35(±0.042) -4.95(±0.07) 
𝐾𝜑 ,𝑠
∘ ·106 (m3 mol-1GPa-1) -21.22(±0.08) -19.28(±0.10) -17.64(±0.08) -14.96(±0.08) -12.61(±0.08) 
SK ·10
6 ( kg m3 mol-2GPa-1) -25.10(±0.44) -24.99(±0.53) -27.22(±0.44) -32.38(±0.43) -34.71(±0.40) 
0.04 mB sulphathiazole + glycine 
𝑉𝜑
0·106 (m3 mol-1) 45.96(±0.009) 46.81(±0.009) 47.32(±0.009) 47.98(±0.009) 48.36(±0.01) 
Sv·10
6 (m3 kg1/2mol-3/2) -2.02(±0.046) -4.50((±0.05) -7.04(±0.05) -7.69(±0.04) -8.66(±0.06) 
𝐾𝜑 ,𝑠
∘ ·106 (m3 mol-1GPa-1) -22.75(±0.08) -20.09(±0.10) -18.70(±.0.16) -17.58(±0.2) -15.45(±0.13) 
SK ·10
6 (kg m3 mol-2GPa-1) -29.98(±0.45) -30.27(±0.52) -26.35(±0.83) -29.58(±1.05) -25.89(±0.69) 
𝑉𝜑
0 and 𝐾𝜑 ,𝑠
∘  for glycine in water at the temperatures of (288.15, 293.15, 298.15, 303.15, and 308.15) K are taken from the references 28, 
31 and 32 




Partial molar properties of transfer 
The transfer partial molar volumes (𝛥𝑡𝑟𝑉𝜑
∘) and 
transfer partial molar adiabatic compressibilities 
(𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘ ) at infinite dilution of glycine from water to 





Y  (in aqueous sulphathiazole solutions)  
– 
0
Y  (in water) … (5) 
The experimental values 𝑉𝜑
0 and 𝐾𝜑 ,𝑠
0 for glycine in 
water at T= (288.15, 293.15, 298.15, 303.15, and 
308.15) K have been taken from literatures
32,35,36
. The 
calculated results are given in Table 4 and illustrated 
in Figs 2 and 3. The values of 𝛥𝑡𝑟𝑉𝜑
∘ and (𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘ ) are 
by definition free from solute- solute interactions
37
 
and thereby provide qualitative and quantitative 
information regarding the interactions of a co-solvent 
and a solute as at infinite dilution the interactions 
between solute molecules become negligible. Table 4 
and Figs 2 and 3 show that 𝛥𝑡𝑟𝑉𝜑
∘ and 𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘  are 
positive. From the data, it has been remarked that the 
𝛥𝑡𝑟𝑉𝜑
∘ values increase with elevation in temperature 
for all concentrations of drug. The positive 𝛥𝑡𝑟𝑉𝜑
∘ 
value stands for the expansion in volume of glycine in 




∘ value can further be explained on the 
basis of co-sphere overlap model
40,41
. According to 
this model, it is suggested that, in the ternary solutions 
sulpha drug –glycine-water, the ionic-hydrophilic and 
hydrophilic-hydrophilic group interactions contribute 
positively, whereas the hydrophilic-hydrophobic 
group interactions contribute negatively to the 𝛥𝑡𝑟𝑉𝜑
∘ 
values. It can also be seen in Table 4 and Fig. 2 that 
the transfer volume increases with increasing 
concentrations of drug. It may be concluded that in 
the ternary solutions, the increased concentrations  
of drug lead to greater ionic-hydrophilic and 
 
 
Fig. 2 — Plots of transfer partial molar volume, 𝛥𝑡𝑟𝑉𝜑
𝑜  at infinite 
dilution versus molality of sulphathiazole drug at T= (■, 288.15 K; ●, 




Fig. 3 — Plots of transfer partial molar adiabatic compressibility, 
𝛥𝑡𝑟𝐾𝜑 ,𝑠
𝑜 at infinite dilution versus molality of sulphathiazole  
drug at T= (■, 288.15 K; ●, 293.15 K; ▲, 298.15 K; ▼,  
303.15 K; ○, 308.15 K) 
Table 4 — Transfer partial molar volumes, 𝛥𝑡𝑟𝑉𝜑
∘ and transfer partial molar adiabatic compressibilities, 𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘  of glycine in aqueous 
solutions of sulphathiazole drug at different temperatures 
T(K) 
mB 
 (mol kg-1) 
𝛥𝑡𝑟𝑉𝜑
∘·106 (m3 mol-1) 𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘ ·106 (m3 mol-1GPa-1) 
 288.15 293.15 298.15 303.15 308.15 288.15 293.15 298.15 303.15 308.15 
0.01 0.57 0.60 0.63 0.69 0.73 14.38 14.26 14.16 13.96 13.83 
0.02 0.96 1.10 1.29 1.49 1.68 13.07 12.75 12.48 12.37 12.28 
0.03 2.65 2.73 2.82 2.97 3.06 10.44 10.26 9.88 9.35 9.16 
0.04 3.76 3.91 4.08 4.32 4.48 8.91 8.31 7.80 7.26 6.85 
mB stands for the molality of solvent (i.e. aqueous sulphathiazole solution) 









 group of glycine and sulfuric( ) group of 
sulpha drug that are not influenced by the 
hydrophilic-hydrophobic interactions. 
The 𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘  values decrease both with increase in 
concentration of sulphathiazole drug and temperature. 
The observed increase in 𝛥𝑡𝑟𝑉𝜑
∘ and decrease in 𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘  
values for glycine in aqueous drug solutions with an 
increase of temperature may be attributed to the 
corresponding decrease in the number of electrostricted 
water molecules and, thereby structure making tendency 
of the ions increases. That is, the release of water 
molecules to solvent bulk occurs due to disruption of 
hydration sphere of the charged end centers of glycine 
and sulphathiazole drug. As a result, it also leads to 
larger decrease in the compressibility with increase in 
sulphathiazole concentration. Thus, K,s
0 
values are 
negative and 𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘ values are positive. 
The pair and triplet interaction coefficients 
estimated from 𝛥𝑡𝑟𝑉𝜑
∘ and 𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘  values as discussed 
in our previous paper
42
 using the following equation 
𝛥𝑡𝑟𝑌𝜑
∘ 𝑤𝑎𝑡𝑒𝑟 𝑡𝑜 𝑎𝑞𝑢𝑒𝑜𝑢𝑠 𝑐𝑜𝑠𝑜𝑙𝑢𝑡𝑒 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 =
2𝑌𝐴𝐵𝑚𝐵 + 3𝑌𝐴𝐵𝐵𝑚𝐵
2  … (6) 
where the constants YAB and YABB are pairwise and triplet 
interaction coefficients. Here A denotes glycine, B 
denotes the co-solute (drug), and mB is the molality of 
the co-solute. The 𝛥𝑡𝑟𝑌𝜑
∘ values have been fitted to  
Eqn 6 to obtain YAB
 
and YABB. The corresponding 
parameters VAB and VABB for volumes and KAB and KABB 
for adiabatic compressibilities, estimated from 𝛥𝑡𝑟𝑉𝜑
∘ 
and 𝛥𝑡𝑟𝐾𝜑 ,𝑠
∘ , respectively, are listed in Table 5.The pair 
wise interaction coefficients VAB and VABB are positive 
for sulpha drug at all temperatures for glycine. Positive 
values for VAB strengthen our viewpoint that ionic/ 
hydrophilic-hydrophilic interactions dominate over 
hydrophobic- ionic interactions between solute and co-
solute molecules. The values of VAB for glycine increase 
with increase in temperature. The pairwise interaction 
coefficient KAB corresponding to the compressibility  
is also positive and it decreases with increase in 
temperature. 
 
Apparent molar expansibilities 
The temperature variation of 𝑉𝜑
0 can be expressed as 
𝑉𝜑
0 = 𝑎 + 𝑏(𝑇 − 𝑇𝑚 ) + 𝑐(𝑇 − 𝑇𝑚 )
2 … (7) 
where Tm represents the midpoint temperature of the 
range used (Tm =298.15 K). Least- square fitting of 
Eqn 7 was done to obtain a, b, and c parameters. 
Differentiation of Eqn 7 with respect to 
temperature at constant pressure was done to calculate 
partial molar isobaric expansions 
𝐸2
𝑜 =  (𝜕𝑉𝜑
0 𝜕𝑇 )𝑃 = 𝑏 + 2𝑐(𝑇 − 𝑇𝑚 ) … (8) 
It follows from Eqn 8 that the quantity b+2c 
(T-Tm) is equivalent to 𝐸2
𝑜 . The calculated values of 
partial molar expansion, 𝐸2
𝑜 , at different temperatures 
are included in Table 6. From this table, it has been 
seen that at each temperature 𝐸2
𝑜  value for any solute 





(m 3 mol-2 kg) 
VABB 
·108 
(m 3 mol-3 kg2) 
KAB ·10
8 
(m 3 mol-2 kg GPa-1) 
KABB 
·109 
(m 3 mol-3 kg2 GPa-1) 
288.15 14.35(±11.25) -5.62(±2.18) 6.23(±1.55) -8.88(±3.03) 
293.15 17.26(± 9.44) -5.42(±1.83) 6.19((±1.53) -8.93((±2.97) 
298.15 21.25(± 6.81) -5.08(±1.32) 6.13(±1.53) -8.93(±2.98) 
303.15 25.21(±5.01) -4.88(±0.97) 6.08(±1.53) -8.96(±2.97) 
308.15 30.18(± 2.46) -4.36(±0.47) 6.06(±1.50) -9.01(±2.92) 
 
Table 6 — Partial molar expansions, 𝐸2
0 at infinite dilution and isobaric thermal expansion coefficient, α2 of glycine in aqueous 
sulphathiazole solutions at different temperatures 
mB (mol kg
-1) 𝐸2
0·106 (m3 mol-1 K-1) 
288.15 K 293.15 K 298.15 K 303.15 K 308.15 K 
0.01 0.0002 0.0030 0.0045 0.0060 0.0075 
0.02 0.0012 0.0037 0.0062 0.0087 0.0112 
0.03 0.0135 0.0170 0.0205 0.0240 0.0275 
0.04 0.0280 0.0320 0.0360 0.0400 0.0440 
 α2 (K) 
0.01 0.00003 0.00007 0.00010 0.00013 0.00017 
0.02 0.00003 0.00008 0.00014 0.00019 0.00024 
0.03 0.00030 0.00037 0.00044 0.00051 0.00058 
0.04 0.00059 0.00067 0.00076 0.00083 0.00090 




thought to be sensitive measure of solute-solvent 
interaction. From Table 6, it has been seen that at 
each temperature 𝐸2
𝑜  value in aqueous drug solution 
are increasing regularly with rise in temperature, and 
with the concentration of sulphathiazole drug. It may 
be noted that 𝐸2
𝑜  values are positive favouring the 
solute-solute interactions. 
The effect is that electrostricted water may be 
released from the loose salvation layer of glycine. 
Removal of water molecules favours glycine-drug or 
drug-drug interactions, indicating the value of partial 
molar expansibility gives information regarding the 
size of the solute and its hydrophobicity. 
The values of 𝑉𝜑
0 and 𝐸2
𝑜  are further used to 
calculate the isobaric thermal expansion coefficient, 




𝑜  … (9) 




The calculated values of α2 are included in  
Table 6. The α2 values increase with increase in 
temperature as well as with increase in concentration 
of sulphathiazole drug indicating that amino acid-




Further as a part of our study, the absorption 
spectra were recorded for different mixtures to 
analyze the solute- solvent interactions. The spectra 
for different concentrations of glycine in different 
aqueous drug solutions are shown in Fig. 4 at 298.15 K. 
The values of observed absorption maximum are 
reported in Table 7. From the spectra, it is observed 
that absorption maximum increases with increase in 
 
 
Fig. 4 — Absorption spectra (plot of molality of glycine versus 
absorbance) for 0.01m sulphathiazole drug solution at 298.15 K 
Table 7 — Absorption and emission spectra of glycine with different concentrations of aqueous sulphathiazole drug solutions 
mA(mol kg
-1) Absorbance Wavelength (nm) log10 ε Intensity 
0.01 mBsulphathiazole + glycine   
0.05 0.377 318 0.8414 303.234 
0.10 0.448 318 0.6884 371.399 
0.15 0.501 318 0.5289 429.161 
0.20 0.546 318 0.4594 445.997 
0.25 0.594 318 0.3758 637.549 
0.30 0.638 318 0.2996 815.611 
0.02 mBsulphathiazole + glycine   
0.05 0.234 322 0.6702 142.887 
0.10 0.316 322 0.5263 257.269 
0.15 0.383 322 0.4292 301.527 
0.20 0.449 322 0.3512 346.218 
0.25 0.516 322 0.3147 397.417 
0.30 0.561 322 0.2718 438.780 
0.03 mBsulphathiazole + glycine   
0.05 0.135 324 0.3222 113.514 
0.10 0.227 324 0.4579 201.704 
0.15 0.304 324 0.3344 276.351 
0.20 0.378 324 0.3096 420.322 
0.25 0.457 324 0.2769 593.850 
0.30 0.516 324 0.2355 855.510 
0.04 mBsulphathiazole + glycine   
0.05 0.070 327 0.1461 65.310 
0.10 0.120 327 0.0790 266.640 
0.15 0.185 327 0.0660 337.810 
0.20 0.257 327 0.0910 546.346 
0.25 0.329 327 0.1192 616.147 
0.30 0.429 327 0.2209 667.128 






 and this feature is similar to 
that observed for apparent molar volumes. Further, 
the spectra recorded for a fixed composition of 
glycine in different aqueous drug solution shows 
regular decrease in absorption maximum with 
increase in concentration of sulphathiazole drug 
solution i.e from 0.01-0.04 mol kg
-1
. The 
bathochromic shift observed in case of glycine with 
aqueous drug solution indicates the coordination of 
ions of sulphathiazole with glycine by breaking the 
solvent layers of water that causes extended 
conjugation resonance
45
. This effect is attributed to 
the corresponding increase in attraction between 
glycine and aqueous sulphathaizole solution. This 
clearly supports and justifies our thermodynamic data. 
 
Conclusions 
In this paper, we have presented the volumetric  
and adiabatic properties of glycine in aqueous 
sulphathiazole drug solutions at different 
temperatures. The apparent molar volume values are 
positive and apparent molar compressibility values 
are negative in aqueous drug solutions, indicating the 
presence of strong solute-solvent interactions. The 
observed positive values of transfer partial molar 
volumes and transfer partial molar adiabatic 
compressibilities in ternary solutions sulpha drug –
glycine – water suggest that the ion-hydrophilic and 
hydrophilic – hydrophilic interactions predominate 
over the hydrophilic- hydrophobic group interactions. 
From the spectra, it is observed that absorption 
maximum increases with increase in concentration of 
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